Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:22:36.531Z.
Consensus retrieved: 2026-10-06T15:25:37.196Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:22:36.531Z.
Quote observation: 2026-10-06T18:18:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 93909054c420831b7a71ade485d1565ba09f3c5b60377b98c71c30749e6fc511
Forward PE Ratio (N/A) = Dated Quote Price ($0.88) / Consensus Forward EPS ($-176.40)
FORWARD PE RATIO
N/A
PRF Technologies Ltd.
Market Cap
$71110.00
Forward PE Ratio
N/A
Market Cap
$30509.00
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| PRF Technologies Ltd. (PRFX) | $71110.00 | N/A |
| Akanda Corp. (AKAN)vs › | $61495.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108729.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $31083.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6115.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.88, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-176.40 | $-176.40 – $-176.40 | 1 | n/m |
| 2027-12-31 | $-129.60 | $-129.60 – $-129.60 | 1 | n/m |
| 2028-12-31 | $19.20 | $19.20 – $19.20 | 1 | 0.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
